pharmaphorum

NOVEMBER 30, 2022

Veeva Systems invited pharmaphorum to attend its industry summit in Madrid this week, a huge event that gathered together over 1,000 individuals from life sciences and pharma. The question is, how can the journey there be accelerated, when on the horizon awaits a life sciences future very much immersed in speciality medicine?

Life Science 98

Life Science Pharma Companies Sales Marketing 98

Pharmaceutical Technology

JANUARY 31, 2023

Inflation Reduction Act Speaking during the keynote panel “FDA & ARPA-H: Life Sciences, Biopharma & Medtech Priorities in a New Year”, Califf discussed the Inflation Reduction Act of August 2022, which aims to lower prescription drug prices. That leaves three years for pharma companies to prepare. It’s a hot area.”

Drugs 130

Drugs Gene Therapy Regulation Insulin 130

pharmaphorum

SEPTEMBER 17, 2021

Havas Life Medicom, ARK and Pharmadoctor top the agency charts AstraZeneca, klarify and Novartis Gene Therapies top the pharma leader board. Among pharma companies and healthcare organisations, the top three companies, taking two Golds each, were AstraZeneca, klarify and Novartis Gene Therapies.

Gene Therapy 52

Gene Therapy Gene Allergies Life Science 52

The Pharma Data

DECEMBER 17, 2020

Smith joined SpringWorks at the company’s inception in 2017 and was a founding member of the management team. Prior to SpringWorks, Smith was the executive vice president of Gene Therapy at Bamboo Therapeutics. Recro – CDMO company Recro announced David Enloe as its new president and CEO. based Rinri Therapeutics.

Development 52

Development Gene Therapy Engineer Life Science 52

The Pharma Data

NOVEMBER 10, 2020

By giving companies full control of their studies, they are able to significantly speed up timelines,” Tessier said. The intricate specialties of oncology and neurology combined make up over 50% of Mispro’s client base, with immunology and gene therapy taking 14% of the pie, respectively. .

Marketing 52

Marketing In-Vivo Scientist Research 52

XTalks

DECEMBER 29, 2022

The life sciences and healthcare are among the biggest industries globally, and their significance was particularly highlighted during the past couple of years by the COVID-19 pandemic. Given the hyperfocus on the life sciences thanks to COVID, consumers appear to be more autonomous and vocal about their medical demands and choices.

Life Science 52

Life Science Gene Therapy Gene Manufacturing 52

Pharmaceutical Technology

FEBRUARY 13, 2023

Several biotech companies and researchers are now exploring medical devices and gene therapies to address not just common forms of epilepsy, but also rare conditions such as Dravet Syndrome. To tackle this, companies have developed different ways to focus on the gene.

Research 264

Research Gene Gene Therapy Genome 264

XTalks

OCTOBER 4, 2023

Heather McDonald: My previous role at Bayer was a global-level role with a specific focus on cell and gene therapies. In addition, AstraZeneca just announced a major acquisition of Pfizer’s cell and gene therapy portfolio. How is the shift toward value-based healthcare affecting drug pricing and reimbursement?

Marketing 106

Marketing Development Drugs Gene Therapy 106

pharmaphorum

NOVEMBER 23, 2022

A director in life sciences consulting for EY, she works within the commercial space for such companies, as well as their clients. “My We looked at the areas of rare diseases, cell and gene therapy, vaccines – loads of different perspectives. Innovative offerings around market access. About the interviewees.

Life Science 98

Life Science Marketing Medicine Production 98

XTalks

MARCH 28, 2024

Bettica said the company’s focus is to now “make Duvyzat available as a treatment for DMD management in the US as quickly as possible.” Duvyzat will be competing with Sarepta Therapeutics’ bag of exon-skipping DMD therapies, which include Exondys 51 (eteplirsen), Vyondys (golodirsen) and Amondys (casimersen).

FDA Approval 106

FDA Approval Genetics Gene Therapy Gene 106

XTalks

FEBRUARY 16, 2022

In this episode, Ayesha discussed the NHS’s recommendation of Libmeldy, a gene therapy for the treatment of the rare disease MLD, which is officially the world’s most expensive drug with a list price of almost $4 million USD. New Report Finds Whopping Increase in Pharma Cybersecurity Threats.

Life Science 52

Life Science Gene Therapy Drugs Pharma Companies 52

XTalks

OCTOBER 22, 2020

In this sense, pharmaceutical companies have developed different strategies to produce a wide variety of advanced therapy medicinal products (ATMP) and biological products, such as monoclonal antibodies, recombinant proteins, gene therapy viral vectors, CAR-T cells and oncolytic viruses, in order to deliver new medical needs in our society.

Manufacturing 98

Manufacturing Development Production Gene Therapy 98

Pharmaceutical Technology

MAY 26, 2023

Tripling its production capacity, Touchlight can now manufacture 8kg plasmid DNA, a key component for mRNA gene therapies and vaccines. The British company’s expanded facilities boasts of 11 suites, including two class B filling suites with class A filling cabinets, warehousing and quality control laboratory capability.

DNA 130

DNA Manufacturing Gene Gene Therapy 130

XTalks

MARCH 22, 2023

In October 2022, Xtalks celebrated two decades of bringing diverse stakeholders in the life science industry together through first holding physical events, then soon after, hosting exclusively online events. And drugmakers are using their R&D expenditure to justify setting astronomically high list prices for new therapies.

Life Science 97

Life Science Drugs FDA Approval Vaccination 97

Pharmaceutical Technology

APRIL 24, 2023

Biologics are costly to produce and sell, and the more recent modalities, such as cell and gene therapies, can be difficult to manufacture. There are fewer sites for cell and gene therapies and vaccines – 90 companies with 127 facilities, as per GlobalData figures.

Contract Manufacturing 130

Contract Manufacturing Manufacturing Protein Sales 130

Delveinsight

AUGUST 4, 2021

Similarly, other companies in the domain such as Eisai/ BioArctic AB, Hoffmann-La Roche/Chugai Pharmaceuticals, Anavex Life Sciences Corp., Pharmacological therapies can only limit or slow down symptoms of PD. In June 2021, Aducanumab by Biogen received FDA approval to treat patients with Alzheimer’s disease.

Marketing 98

Marketing Genetics Development Clinical Development 98

XTalks

DECEMBER 20, 2023

In 2023, there were significant advancements and notable trends in the life sciences. Xtalks compiled a list of its top life science news and trends of 2023, which provided readers with the latest developments, information and expert insights across life science industries, including pharma, biotech and medical device.

Life Science 59

Life Science Clinical Trials Clinical Trials FDA Approval 59

XTalks

MAY 29, 2024

The top ten pharma companies in 2023 by revenue accounted for about 35 percent of the market value, with total earnings of $559.5 The top big pharma players have remained relatively consistent in their market positions over the past several years. Here is a look at the top ten pharma companies in 2024 based on 2023 revenue.

Pharma Companies 52

Pharma Companies Sales FDA Approval Vaccination 52

XTalks

JANUARY 6, 2025

Cell and Gene Therapies Cell and gene therapies (C&GT) remain at the forefront of healthcare innovation, representing one of the fastest-growing therapeutic areas. As of March 18, 2024, the FDA has approved 36 gene therapies, with an additional 500 therapies in the pipeline.

Gene Therapy 111

Gene Therapy RNA Gene Editing Gene 111

XTalks

FEBRUARY 11, 2025

Pediatric cancer care has traditionally relied on chemotherapy, radiation and surgery, but emerging therapies are expanding possibilities. Advances in Research and Treatment Recent efforts by global pharma companies reflect a renewed commitment to childhood cancer.

Gene Therapy 66

Gene Therapy Clinical Trials Clinical Trials Trials 66